Piperazine

Piperazine

SCHEMBL5875243

C1CNCCN1.C1CNCCN1.O=S(=O)(O)O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.50
CA5A P35218 2/20 0.50
CA5B Q9Y2D0 2/20 0.50
GABRA1 P14867 2/20 0.50
GABRG2 P18507 2/20 0.50
GABRB3 P28472 2/20 0.50
GABRA5 P31644 2/20 0.50
GABRA3 P34903 2/20 0.50
GABRA2 P47869 2/20 0.50
GABRA6 Q16445 2/20 0.50
LMNA P02545 1/20 0.50
CYP3A4 P08684 1/20 0.50
NFKB1 P19838 1/20 0.50
HIF1A Q16665 1/20 0.50
MAPT P10636 1/20 0.50
PDE4A P27815 1/20 0.50
KDR P35968 1/20 0.50
CXCR4 P61073 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KDM4E B2RXH2 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL8300104 1.00 TSHR (0.50) TSHRCA5ACA5BGABRA1GABRG2
Sulfuric Acid SCHEMBL6260312 1.00 TSHR (0.50) TSHRCA5ACA5BGABRA1GABRG2
Sulfuric Acid SCHEMBL6099988 1.00 TSHR (0.50) TSHRCA5ACA5BGABRA1GABRG2
Sulfuric Acid SCHEMBL6099992 1.00 TSHR (0.50) TSHRCA5ACA5BGABRA1GABRG2
Sulfuric Acid SCHEMBL8291975 1.00 TSHR (0.50) TSHRCA5ACA5BGABRA1GABRG2
Piperazine SCHEMBL27978492 1.00 TSHR (0.50) TSHRCA5ACA5BGABRA1GABRG2
Piperazine SCHEMBL2445779 1.00 TSHR (0.50) TSHRCA5ACA5BGABRA1GABRG2
Piperazine SCHEMBL30708072 0.96 TSHR (0.48) TSHRCA5ACA5BGABRA1GABRG2
Piperazine SCHEMBL30517943 0.96 TSHR (0.48) TSHRCA5ACA5BGABRA1GABRG2
Sulfuric Acid SCHEMBL4097784 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023126969-A1 ORAL FILMS OF ANIT-PARASITIC DRUGS LAURUS LABS LIMITED (IN) 2023-07-06 WO disclosed
CN-111683653-A Methods and compositions for topical delivery 伊拉斯吹斯制药有限公司 2020-09-18 CN disclosed
EP-3694489-A2 METHODS AND COMPOSITIONS FOR TOPICAL DELIVERY Illustris Pharmaceuticals, Inc. (US) 2020-08-19 EP disclosed
WO-2019075263-A2 METHODS AND COMPOSITIONS FOR TOPICAL DELIVERY ILLUSTRIS PHARMACEUTICALS, INC. (US) 2019-04-18 WO disclosed
US-20190105261-A1 METHODS AND COMPOSITIONS FOR TOPICAL DELIVERY ILLUSTRIS PHARMACEUTICALS, INC. 2019-04-11 US disclosed
EP-3442488-A1 COMPOSITIONS FOR TOPICAL APPLICATION OF COMPOUNDS Illustris Pharmaceuticals, Inc. (US) 2019-02-20 EP disclosed
US-20190008795-A1 COMPOSITIONS FOR TOPICAL APPLICATION OF COMPOUNDS ILLUSTRIS PHARMACEUTICALS, INC. 2019-01-10 US disclosed
CN-109152702-A COMPOSITIONS FOR TOPICAL APPLICATION OF COMPOUNDS 伊拉斯吹斯制药有限公司 2019-01-04 CN disclosed
WO-2017180788-A1 COMPOSITIONS FOR TOPICAL APPLICATION OF COMPOUNDS ILLUSTRIS PHARMACEUTICALS, INC. (US) 2017-10-19 WO disclosed
US-20170290778-A1 COMPOSITIONS FOR TOPICAL APPLICATION OF COMPOUNDS ILLUSTRIS PHARMACEUTICALS, INC. 2017-10-12 US disclosed
US-7128976-B2 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2006-10-31 US disclosed
US-20030091838-A1 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2003-05-15 US disclosed
EP-0789080-A2 Process for the preparation of organic aminium lactates and their use in the preparation of dilactide Gesellschaft für ökologische Technologie und Systemanalyse e.V. (DE) 1997-08-13 EP disclosed